Sodium Bicarbonate → 1-[2-[3-(3,4-Dichloro-phenyl)-1-(benzoyl)-pyrrolidin-3-yl]-ethyl]-4-phenylpiperidine-4-carboxylic acid amide

HRID 1682935Notes

Reaction equation

HRID 1682935 reaction equation
CS(O[CH2:6][CH2:7][C:8]1([C:21]2[CH:26]=[CH:25][C:24]([Cl:27])=[C:23]([Cl:28])[CH:22]=2)[CH2:12][CH2:11][N:10]([C:13](=[O:20])[C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[CH2:9]1)(=O)=O.Cl.[C:30]1([C:36]2([C:42]([NH2:44])=[O:43])[CH2:41][CH2:40][NH:39][CH2:38][CH2:37]2)[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1.C([O-])(O)=O.[Na+]>C1COCC1>[Cl:28][C:23]1[CH:22]=[C:21]([C:8]2([CH2:7][CH2:6][N:39]3[CH2:38][CH2:37][C:36]([C:30]4[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=4)([C:42]([NH2:44])=[O:43])[CH2:41][CH2:40]3)[CH2:12][CH2:11][N:10]([C:13](=[O:20])[C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=3)[CH2:9]2)[CH:26]=[CH:25][C:24]=1[Cl:27]

Participants

5

Procedure

2-[1-Benzoyl-3-(3,4-dichloro-phenyl)-pyrrolidin-3-yl]ethyl methanesulfonate (191 mg, 0.43 mmol) was treated with the 4-phenyl-piperidine-4-carboxylic acid amide hydrochloride (144 mg, 0.599 mmol) and NaHCO3 (90 mg, 1.07 mmol, 2.5 eq.) in THF/H20 (5 mL/1 mL) at reflux for 21 hours. The solution was concentrated in vacuo and the aqueous phase was extracted with dichloromethane. The organic phase was dried over magnesium sulfate, filtered, and concentrated in vacuo. The residue was chromatographed on silica gel (30 g) with 6% methanol in dichloromethane to give 146 mg (44%).

Workup

  1. temperatureat reflux for 21 hours
  2. concentrationThe solution was concentrated in vacuo
  3. extractionthe aqueous phase was extracted with dichloromethane
  4. dry with materialThe organic phase was dried over magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customThe residue was chromatographed on silica gel (30 g) with 6% methanol in dichloromethane
  8. customto give 146 mg (44%)

Sources & evidence

ORD record
ord-314e4a2a6f904c1da815f189009fdd96
Source dataset
uspto-grants-1997_06
Patent number
US05635510

Reaction notes

Loading…